Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls

Pharmacogenomics. 2018 Jan;19(2):95-104. doi: 10.2217/pgs-2017-0134. Epub 2017 Dec 6.

Abstract

Aim: To determine whether specific dopaminergic system gene variants are associated with opioid dependence.

Patients & methods: Subjects included 153 healthy controls, 163 opioid exposed, but not dependent and 281 opioid dependent. Genotypes of 90 variants in 13 genes were examined.

Results: The most significant results were obtained for DA β-hydroxylase variants, rs2073837 and rs1611131, which were associated with protection from addiction (q = 0.0172, 0.0415, respectively) and the functional TH variant, rs2070762, was associated with more risk (q = 0.0387). The three variants also showed a combined effect that remained significant after correction for multiple testing (pfinal = 0.0039).

Conclusion: These data offer support that dopaminergic gene variants have a role in opioid dependence and warrant further study.

Keywords: DBH; TH; drug addiction.

MeSH terms

  • Adult
  • Analgesics, Opioid / adverse effects
  • Behavior, Addictive / chemically induced
  • Behavior, Addictive / genetics*
  • Case-Control Studies
  • Dopamine / genetics*
  • Dopamine beta-Hydroxylase / genetics
  • Female
  • Genotype
  • Humans
  • Male
  • Opioid-Related Disorders / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Risk

Substances

  • Analgesics, Opioid
  • Dopamine beta-Hydroxylase
  • Dopamine